BIANCHI, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 8.671
EU - Europa 4.080
AS - Asia 4.015
SA - Sud America 482
AF - Africa 108
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 12
Totale 17.393
Nazione #
US - Stati Uniti d'America 8.496
GB - Regno Unito 1.273
SG - Singapore 1.110
IT - Italia 1.064
CN - Cina 923
HK - Hong Kong 555
VN - Vietnam 446
SE - Svezia 429
BR - Brasile 345
DE - Germania 273
FR - Francia 224
BD - Bangladesh 223
RU - Federazione Russa 189
FI - Finlandia 142
KR - Corea 140
TR - Turchia 134
UA - Ucraina 134
CA - Canada 113
IN - India 92
ID - Indonesia 82
NL - Olanda 54
BG - Bulgaria 48
JP - Giappone 44
AR - Argentina 43
IR - Iran 42
IQ - Iraq 37
MX - Messico 35
PL - Polonia 32
ZA - Sudafrica 32
SI - Slovenia 30
LT - Lituania 25
AU - Australia 23
BE - Belgio 23
CO - Colombia 22
ES - Italia 22
PK - Pakistan 22
EC - Ecuador 20
SA - Arabia Saudita 19
AE - Emirati Arabi Uniti 18
CZ - Repubblica Ceca 18
KE - Kenya 17
QA - Qatar 17
EG - Egitto 16
IE - Irlanda 16
UZ - Uzbekistan 15
CL - Cile 14
MY - Malesia 13
CH - Svizzera 12
MA - Marocco 11
AT - Austria 10
DZ - Algeria 9
EU - Europa 9
JO - Giordania 9
PY - Paraguay 9
TW - Taiwan 9
BO - Bolivia 8
GR - Grecia 8
PH - Filippine 8
VE - Venezuela 8
LU - Lussemburgo 7
PT - Portogallo 7
PE - Perù 6
SV - El Salvador 6
TH - Thailandia 6
TN - Tunisia 6
AL - Albania 5
AZ - Azerbaigian 5
DK - Danimarca 5
IL - Israele 5
JM - Giamaica 5
MN - Mongolia 5
NP - Nepal 5
OM - Oman 5
RO - Romania 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
LB - Libano 4
NO - Norvegia 4
PS - Palestinian Territory 4
SN - Senegal 4
HR - Croazia 3
KZ - Kazakistan 3
NI - Nicaragua 3
RS - Serbia 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BH - Bahrain 2
BW - Botswana 2
BY - Bielorussia 2
EE - Estonia 2
GT - Guatemala 2
KG - Kirghizistan 2
KW - Kuwait 2
MK - Macedonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 17.367
Città #
Ashburn 982
Southend 949
Fairfield 818
Singapore 686
Santa Clara 673
Hong Kong 535
Chandler 464
Woodbridge 428
San Jose 418
Houston 403
Seattle 305
Cambridge 281
Wilmington 259
Ann Arbor 250
Nyköping 215
Modena 208
Beijing 206
Dearborn 199
Jacksonville 190
Council Bluffs 187
Hefei 187
London 166
Los Angeles 158
New York 135
Ho Chi Minh City 133
Chicago 125
Seoul 119
Hanoi 102
The Dalles 93
Helsinki 78
San Diego 78
Milan 76
Izmir 71
Jakarta 63
Salt Lake City 54
Shanghai 51
Lauterbourg 49
Munich 49
Princeton 49
Buffalo 48
Fremont 48
Dallas 47
Sofia 47
Bologna 46
Eugene 44
Rome 43
Reggio Emilia 39
Shenzhen 38
São Paulo 38
Moscow 36
Sant'Ilario d'Enza 36
Montreal 33
Tampa 33
Tokyo 32
Toronto 32
Elk Grove Village 29
Orem 29
Frankfurt am Main 28
Turku 26
Dong Ket 25
Phoenix 25
Des Moines 23
Bremen 22
Hillsboro 22
Boardman 21
Naples 21
Da Nang 20
Parma 20
Redwood City 20
Brussels 19
Columbus 19
Warsaw 19
Haiphong 18
Nuremberg 17
Atlanta 16
Chennai 16
Doha 16
Florence 16
Johannesburg 16
Nairobi 16
Poplar 16
Dublin 15
Falls Church 15
Amsterdam 14
Manchester 14
Denver 13
Guangzhou 13
Tashkent 13
Turin 13
Belo Horizonte 12
Las Vegas 12
Sterling 12
Biên Hòa 11
Brooklyn 11
Miami 11
Palermo 11
Brasília 10
Brno 10
Jinan 10
Lancaster 10
Totale 11.897
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 569
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 513
c-Myb supports erythropoiesis by transactivating KLF1 and LMO2 expression 492
miR-382-5p Controls Hematopoietic Stem Cell Differentiation Through the Downregulation of MXD1 454
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 450
C-Myb Restrains Megakaryopoiesis through the Hsa-MiR-486-3p-Driven Down-Regulation of C-Maf 429
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 414
Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice 403
Genomic landscape of megakaryopoiesis and platelet function defects 400
Eosinophils, but not neutrophils, exibit an efficient DNA repair machinary and high nucleolar activity 399
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 395
Co-culture of hematopoietic stem/progenitor cells with human osteblasts favours mono/macrophage differentiation at the expense of the erythroid lineage 389
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 376
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 374
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1) 373
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6 368
Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis 361
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 352
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis 348
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis 343
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis 338
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 328
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 327
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 325
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 320
Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression 319
Regulatory Mrna/Microrna Networks in CD34+ Cells From Primary Myelofibrosis 306
HGM 2010 Programme / Abstract 301
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 294
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-miR-299-5p in CD34+ progenitor cells commitment 293
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib 280
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 278
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells 275
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells 271
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 271
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 269
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization 269
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 268
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 263
Regulatory mRNA/microRNA networks in CD34+ cells from Primary Myelofibrosis 261
Molecular and functional characterization of CD133+ stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 259
Genomic analysis of hematopoietic stem cell at the single-cell level: Optimization of cell fixation and whole genome amplification (WGA) protocol 254
Abnormal expression of WT1-as, MEG3 and ANRIL long non-coding RNAs in primary myelofibrosis and their clinical correlates 249
Regulatory mRNA/microRNA networks in CD34+ cells from Primary Myelofibrosis 248
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis 245
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 241
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 239
Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells. the crucial role of PTEN. 231
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 213
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in primary myelofibrosis 209
Comparison between Cultivated Oral Mucosa and Ocular Surface Epithelia for COMET Patients Follow-Up 205
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis 202
MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF 191
Silencing CD34 antigen in human hematopoietic stem cells 183
Targeting exhausted cytotoxic T cells through CTLA‐4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts 171
CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis 101
Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model 25
Totale 17.524
Categoria #
all - tutte 63.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.151


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.191 57 97 143 72 58 77 51 78 119 95 189 155
2022/20231.520 172 192 135 131 190 167 29 135 159 34 74 102
2023/20241.078 49 47 83 112 146 77 200 126 10 31 60 137
2024/20252.899 83 28 50 164 574 451 262 210 264 123 354 336
2025/20265.628 374 182 352 614 984 353 702 230 551 579 363 344
2026/2027110 110 0 0 0 0 0 0 0 0 0 0 0
Totale 17.524